Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Conditions

Sarcoma, Kaposi 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Hodgkin Disease 1Hematologic Neoplasms 1HIV Infections 1Condylomata Acuminata 1Acquired Immunodeficiency Syndrome 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 15Vaccines, Synthetic 10Papillomavirus Vaccines 7Vaccines 5Imiquimod 4Trichloroacetic Acid 3Gels 3human papillomavirus vaccine, L1 type 16, 18 2green tea extract polyphenone E 2Podophyllin 2Human Papillomavirus Recombinant Vaccine nonavalent 2Ethanol 2Duration of Therapy 2Cryotherapy 2Cantharidin 2ranpirnase 1polyphenon E 1nanocurcumin 1hecolin 1berdazimer sodium 1Zinc 1Viusid 1Vaccination 1VP-102 1Tuberculin 1Therapies, Investigational 1Tea 1Surgical Procedures, Operative 1PRA1 protein, Candida albicans 1Omiganan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Condylomata Acuminata × Interleukin-4 × Clear all
NCT05100043 2025-02-19

Interleukin 4 and Interferon Gamma Predictors of Human Papillomavirus Immunotherapy in Warts

Zagazig University

Completed
80 enrolled

Condylomata Acuminata

Data powered by HemOnc (CC BY 4.0) Colophon âš¡